Literature DB >> 18447724

Nonvasculitic autoimmune inflammatory meningoencephalitis as a cause of potentially reversible dementia: report of 4 cases.

Mark K Lyons1, Richard J Caselli, Joseph E Parisi.   

Abstract

The aim of this study is to evaluate the presentation of unusual dementias in 4 patients and correlate these presentations with the histopathological findings after brain biopsy sampling to define a diagnostic entity. The authors detail the cases of 4 patients (2 women, 46 and 56 years of age; and 2 men, 67 and 74 years of age) who presented with acute and subsequently subacute encephalopathies. Their bizarre presenting symptom complexes and the results of neurological examinations, radiographic studies, electroencephalography (EEG) recordings, and serological marker tests are reviewed. The diagnostic surgical procedures and successful treatments in these patients are discussed. All 4 patients underwent craniotomy and excisional brain biopsy sampling as part of a comprehensive evaluation. Histopathological confirmation of nonvasculitic autoimmune inflammatory meningoencephalitis (NAIM) by a neuropathologist was present in all 4 patients. All patients were successfully treated with a course of corticosteroid medication. Nonvasculitic autoimmune inflammatory meningoencephalitis is a potentially treatable form of dementia whose salient features include a younger average age at onset, rapid progression with significant cognitive and behavioral features, absence of family history, abnormal EEG findings, and elevated levels of inflammatory markers. Although it is an invasive procedure, brain biopsy sampling is safe and can offer histological confirmation of this condition. This procedure is important because NAIM can be treated successfully if it is distinguished from the nontreatable dementias that mimic it.

Entities:  

Mesh:

Year:  2008        PMID: 18447724     DOI: 10.3171/JNS/2008/108/5/1024

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  5 in total

1.  Autoimmune encephalopathy.

Authors:  Richard J Caselli; Joseph F Drazkowski; Dean M Wingerchuk
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

2.  Autoimmune dementia: clinical course and predictors of immunotherapy response.

Authors:  Eoin P Flanagan; Andrew McKeon; Vanda A Lennon; Bradley F Boeve; Max R Trenerry; K Meng Tan; Daniel A Drubach; Keith A Josephs; Jeffrey W Britton; Jayawant N Mandrekar; Val Lowe; Joseph E Parisi; Sean J Pittock
Journal:  Mayo Clin Proc       Date:  2010-10       Impact factor: 7.616

3.  Diagnosis and treatment of rapidly progressive dementias.

Authors:  Ross W Paterson; Leonel T Takada; Michael D Geschwind
Journal:  Neurol Clin Pract       Date:  2012-09

Review 4.  Inpatient Management of Encephalopathy.

Authors:  Pramod Reddy; Kaleb Culpepper
Journal:  Cureus       Date:  2022-02-10

5.  High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types.

Authors:  Sarah Doss; Klaus-Peter Wandinger; Bradley T Hyman; Jessica A Panzer; Matthis Synofzik; Bradford Dickerson; Brit Mollenhauer; Clemens R Scherzer; Adrian J Ivinson; Carsten Finke; Ludger Schöls; Jennifer Müller Vom Hagen; Claudia Trenkwalder; Holger Jahn; Markus Höltje; Bharat B Biswal; Lutz Harms; Klemens Ruprecht; Ralph Buchert; Günther U Höglinger; Wolfgang H Oertel; Marcus M Unger; Peter Körtvélyessy; Daniel Bittner; Josef Priller; Eike J Spruth; Friedemann Paul; Andreas Meisel; David R Lynch; Ulrich Dirnagl; Matthias Endres; Bianca Teegen; Christian Probst; Lars Komorowski; Winfried Stöcker; Josep Dalmau; Harald Prüss
Journal:  Ann Clin Transl Neurol       Date:  2014-10-18       Impact factor: 5.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.